Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 240.20
Bid: 240.20
Ask: 240.80
Change: 2.20 (0.92%)
Spread: 0.60 (0.25%)
Open: 240.00
High: 241.00
Low: 237.80
Prev. Close: 238.00
CRST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc

21 Jun 2024 17:30

Lupus alpha Asset Management AG (-) Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc 21-Jun-2024 / 18:30 CET/CEST The issuer is solely responsible for the content of this announcement.


FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Lupus alpha Asset Management AG

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

Crest Nicholson Holdings Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

14.06.2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state “N/A”

N/A

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 5p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

6,401,000

2.49

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 TOTAL:

6,401,000

2.49

 

 

Note: Lupus alpha Asset Management AG does not have discretion regarding voting decisions in respect of 5.180.000 shares. That all included in the total above.

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary shares

Purchase

 

96,000

377,000

2.3606

2.3934

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

20.06.2024

Contact name:

Simona Papenbrock

Telephone number*:

004969 36 50 58 7264

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

 

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
Category Code:RET - Crest Nicholson Holdings Plc
TIDM:-
LEI Code:529900JRIM4CXFEUZK50
Sequence No.:329587
EQS News ID:1930873
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
27th Apr 202010:52 amRNSDisclosure of Rights Attached to Equity Shares
17th Apr 202010:00 amRNSBlock listing Interim Review
9th Apr 20204:02 pmRNSCOVID-19 Update
2nd Apr 20205:10 pmRNSHolding(s) in Company
2nd Apr 20209:35 amRNSHolding(s) in Company
2nd Apr 20209:30 amRNSHolding(s) in Company
24th Mar 20206:24 pmRNSResult of AGM
23rd Mar 20201:58 pmRNSFurther AGM Update
20th Mar 20205:01 pmRNSFurther AGM Update
19th Mar 20207:00 amRNSCOVID-19 Update
19th Mar 20207:00 amRNSAGM Update
16th Mar 20201:55 pmRNSDirector/PDMR Shareholding
5th Mar 202010:30 amRNSDirector/PDMR Shareholding
4th Mar 20201:54 pmRNSHolding(s) in Company
3rd Mar 202011:08 amRNSDirector/PDMR Shareholding
28th Feb 202011:25 amRNSDirector Declaration
25th Feb 20204:56 pmRNSDirector/PDMR Shareholding
17th Feb 20203:20 pmRNSHolding(s) in Company
17th Feb 202011:16 amRNSAnnual Integrated Report and Notice of AGM
13th Feb 20203:50 pmRNSDirector/PDMR Shareholding
6th Feb 202012:37 pmRNSHolding(s) in Company
6th Feb 20208:55 amRNSDirector/PDMR Shareholding
30th Jan 20209:59 amRNSDirector/PDMR Shareholding
28th Jan 20207:00 amRNSDirectorate Change
28th Jan 20207:00 amRNSFinal Results
19th Dec 20197:00 amRNSDirectorate Change
6th Dec 20194:59 pmRNSHolding(s) in Company
12th Nov 20193:49 pmRNSDirectorate Change
5th Nov 201910:35 amRNSFurther re Directorate Change/Cttees - Correction
4th Nov 20195:47 pmRNSFurther re Directorate Change/Committee Membership
31st Oct 20197:00 amRNSStrategic & Trading Update
30th Oct 20193:10 pmRNSAppointment of Joint Broker
24th Oct 20195:03 pmRNSHolding(s) in Company
18th Oct 20193:23 pmRNSHolding(s) in Company
17th Oct 201912:14 pmRNSBlock listing Interim Review
17th Oct 201911:54 amRNSHolding(s) in Company
15th Oct 20193:41 pmRNSHolding(s) in Company
26th Sep 20193:05 pmRNSHolding(s) in Company
23rd Sep 20194:57 pmRNSHolding(s) in Company
23rd Sep 20193:36 pmRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNSDirectorate Change
16th Aug 20198:08 amRNSDirector Declaration
12th Aug 201911:30 amRNSDirectorate Update
31st Jul 20195:01 pmRNSDirector/PDMR Shareholding
29th Jul 20197:48 amRNSDirector Declaration
16th Jul 20192:38 pmRNSHolding(s) in Company
26th Jun 201910:46 amRNSDirector/PDMR Shareholding
21st Jun 20193:42 pmRNSHolding(s) in Company
17th Jun 201911:25 amRNSDirectorate Change
13th Jun 20194:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.